title: [The clinical observation of bipolar transurethral plasma kinetic resection of prostate for high risk benign prostate hyperplasia].
abstract: OBJECTIVE
  To evaluate therapeutic effect and reliability of bipolar transurethral plasma kinetic prostatectomy (TUPKP) for high risk level benign prostatic hyperplasia (BPH).
  
  
  METHODS
  A total of 230 cases of high risk of BPH were treated with TUPKP. Among them, 132 cases with the residual urine of 40 to 420 ml had accepted long term but inefficient medical therapy, 98 cases were suffered with repeating acute urinary retention. One hundred and seventy-three cases with the functional capacity>4 MET were performed the standard transurethral resection of the prostate (TURP), the other 57 cases with the functional capacity<4 MET were accepted the minimally invasive TURP. Among them 12 cases complicated with bladder stones accepted Ho: YAG lithotripsy priory. The international prostate symptom score (IPSS), The maximal urinary flow rate (Qmax) and residual urine of the 2 groups before and after operation were analyzed.
  
  
  RESULTS
  There was no transurethral resection syndrome occurred in both groups. After 3 to 12 months of follow-up postoperatively, the IPSS of the two groups were reduced from (21.9+/-5.7) and (23.7+/-5.0) to (4.4+/-2.3) and (5.5+/-2.4), residual urine were reduced from (61.8+/-18.4) ml and (103.9+/-77.3) ml to (13.0+/-6.2) ml and (15.8+/-6.1) ml, respectively. The Qmax was increased from (5.7+/-3.0) ml/s and (4.8+/-2.8) ml/s to (20.9+/-6.3) ml/s and (16.8+/-3.9) ml/s, there existed significant differences (P<0.01). However the IPSS, Qmax and residual urine of the standard group had progressed more obviously than the minimally invasive TURP group (P<0.05).
  
  
  CONCLUSIONS
  It is safe and effective to use TUPKP for treating high risk patients of BPH with classic TURP and minimally invasive TURP according to different functional capacity. When the functional capacity is more than 4 MET, the standard procedures is preferred.
authors: Department of Urology, Punan Hospital, Shanghai 200125, China. dr.liudingyi@yahoo.com.cn
authors: Ding-yi
authors: DY
authors: Liu
authors: Jiong
authors: J
authors: Gu
authors: Chong-yu
authors: CY
authors: Zhang
authors: Jian
authors: J
authors: Wang
authors: Qi
authors: Q
authors: Tang
authors: Yan-feng
authors: YF
authors: Zhou
authors: Wen-long
authors: WL
authors: Zhou
authors: Ming-wei
authors: MW
authors: Wang
authors: Yu
authors: Y
authors: Zhu
authors: Ju-ping
authors: JP
authors: Zhao
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000379:methods*; D016896:Treatment Outcome